Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL)

NCT03253848 is registered in ClinicalTrials.gov with ECOG-ACRIN Cancer Research Group as lead sponsor.

NCT NCT03253848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03253848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL)
Lead sponsor
ECOG-ACRIN Cancer Research Group
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 26, 2017
Completion date
December 31, 2027
Enrollment
202 (actual)
Sites
294

Conditions

As the registry lists them; a condition with its own page is linked.

acute promyelocytic leukemia with pml-rara, t(15;17)